Bhatia P

References (7)

Title : Thromboxane A2 synthase inhibition ameliorates endothelial dysfunction, memory deficits, oxidative stress and neuroinflammation in rat model of streptozotocin diabetes induced dementia - Bhatia_2021_Physiol.Behav_241_113592
Author(s) : Bhatia P , Singh N
Ref : Physiol Behav , 241 :113592 , 2021
Abstract :
PubMedSearch : Bhatia_2021_Physiol.Behav_241_113592
PubMedID: 34534530

Title : Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia - Bhatia_2020_Int.J.Neurosci__1
Author(s) : Bhatia P , Singh N
Ref : International Journal of Neuroscience , :1 , 2020
Abstract :
PubMedSearch : Bhatia_2020_Int.J.Neurosci__1
PubMedID: 32859137

Title : Ozagrel a thromboxane A2 synthase inhibitor extenuates endothelial dysfunction, oxidative stress and neuroinflammation in rat model of bilateral common carotid artery occlusion induced vascular dementia - Bhatia_2020_Vascul.Pharmacol__106827
Author(s) : Bhatia P , Kaur G , Singh N
Ref : Vascul Pharmacol , :106827 , 2020
Abstract :
PubMedSearch : Bhatia_2020_Vascul.Pharmacol__106827
PubMedID: 33346090

Title : Ameliorative Effect of Phosphodiesterase-5 Inhibitor in Rat Model of Vascular Dementia - Bhatia_2019_Curr.Neurovasc.Res_16_27
Author(s) : Bhatia P , Singh N
Ref : Curr Neurovasc Res , 16 :27 , 2019
Abstract :
PubMedSearch : Bhatia_2019_Curr.Neurovasc.Res_16_27
PubMedID: 30706814

Title : Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets - Zhang_2007_Neuropharmacol_52_1095
Author(s) : Zhang D , Saraf A , Kolasa T , Bhatia P , Zheng GZ , Patel M , Lannoye GS , Richardson P , Stewart A , Rogers JC , Brioni JD , Surowy CS
Ref : Neuropharmacology , 52 :1095 , 2007
Abstract :
PubMedSearch : Zhang_2007_Neuropharmacol_52_1095
PubMedID: 17217969

Title : 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction - Kolasa_2006_J.Med.Chem_49_5093
Author(s) : Kolasa T , Matulenko MA , Hakeem AA , Patel MV , Mortell K , Bhatia P , Henry R , Nakane M , Hsieh GC , Terranova MA , Uchic ME , Miller LN , Chang R , Donnelly-Roberts D , Namovic MT , Hollingsworth PR , Martino B , El Kouhen O , Marsh KC , Wetter JM , Moreland RB , Brioni JD , Stewart AO
Ref : Journal of Medicinal Chemistry , 49 :5093 , 2006
Abstract :
PubMedSearch : Kolasa_2006_J.Med.Chem_49_5093
PubMedID: 16913699

Title : Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction - Cowart_2004_J.Med.Chem_47_3853
Author(s) : Cowart M , Latshaw SP , Bhatia P , Daanen JF , Rohde J , Nelson SL , Patel M , Kolasa T , Nakane M , Uchic ME , Miller LN , Terranova MA , Chang R , Donnelly-Roberts D , Namovic MT , Hollingsworth PR , Martino BR , Lynch JJ, 3rd , Sullivan JP , Hsieh GC , Moreland RB , Brioni JD , Stewart AO
Ref : Journal of Medicinal Chemistry , 47 :3853 , 2004
Abstract :
PubMedSearch : Cowart_2004_J.Med.Chem_47_3853
PubMedID: 15239663